$HAE Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in HAEMONETICS CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in HAEMONETICS CORP. Get notifications about new insider transactions in HAEMONETICS CORP for free.
Page: < prev 1 ... 8 9 10 11 12 13 14 15 16 ... 16 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 29 2010 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | D | 55.19 | 398 | 21,966 | 39,074 | 39.5 K to 39.1 K (-1.01 %) |
Oct 29 2010 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | D | 55.19 | 114 | 6,292 | 39,472 | 39.6 K to 39.5 K (-0.29 %) |
Oct 29 2010 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Grant | A | 0.01 | 13,638 | 136 | 39,586 | 25.9 K to 39.6 K (+52.56 %) |
Sep 14 2010 | HAE | HAEMONETICS CORP | ALLEN PETER M | Chief Marketing Off ... | Option Exercise | M | 21.46 | 1,866 | 40,044 | 87,714 | |
Sep 14 2010 | HAE | HAEMONETICS CORP | ALLEN PETER M | Chief Marketing Off ... | Sell | S | 54.83 | 1,866 | 102,316 | 5,999 | 7.9 K to 6 K (-23.73 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Option Exercise | A | 54.48 | 4,290 | 233,719 | 4,290 | |
Aug 02 2010 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Grant | A | 0.01 | 1,193 | 12 | 2,201 | 1 K to 2.2 K (+118.35 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Option Exercise | A | 54.48 | 4,290 | 233,719 | 4,290 | |
Aug 02 2010 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Grant | A | 0.01 | 1,193 | 12 | 6,915 | 5.7 K to 6.9 K (+20.85 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Option Exercise | A | 54.48 | 4,290 | 233,719 | 4,290 | |
Aug 02 2010 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Grant | A | 0.01 | 1,193 | 12 | 11,501 | 10.3 K to 11.5 K (+11.57 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | MERRIMAN RONALD | Director | Option Exercise | A | 54.48 | 4,290 | 233,719 | 4,290 | |
Aug 02 2010 | HAE | HAEMONETICS CORP | MERRIMAN RONALD | Director | Grant | A | 0.01 | 1,193 | 12 | 5,201 | 4 K to 5.2 K (+29.77 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | FOOTE SUSAN BARTLETT | Director | Option Exercise | A | 54.48 | 4,290 | 233,719 | 4,290 | |
Aug 02 2010 | HAE | HAEMONETICS CORP | FOOTE SUSAN BARTLETT | Director | Grant | A | 0.01 | 1,193 | 12 | 3,201 | 2 K to 3.2 K (+59.41 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Option Exercise | A | 54.48 | 4,290 | 233,719 | 4,290 | |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Grant | A | 0.01 | 1,193 | 12 | 2,201 | 1 K to 2.2 K (+118.35 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | NUTTER BRAD | Chairman of the Boa ... | Option Exercise | A | 54.48 | 4,290 | 233,719 | 4,290 | |
Aug 02 2010 | HAE | HAEMONETICS CORP | NUTTER BRAD | Chairman of the Boa ... | Grant | A | 0.01 | 1,193 | 12 | 10,580 | 9.4 K to 10.6 K (+12.71 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Option Exercise | A | 59.44 | 5,879 | 349,448 | 5,879 | |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Option Exercise | A | 58.46 | 5,664 | 331,117 | 5,664 | |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Option Exercise | A | 54.48 | 4,290 | 233,719 | 4,290 | |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Option Exercise | A | 52.76 | 6,000 | 316,560 | 6,000 | |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Option Exercise | A | 49.92 | 4,592 | 229,233 | 4,592 | |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Option Exercise | A | 44.74 | 6,000 | 268,440 | 6,000 | |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Option Exercise | A | 26.11 | 6,000 | 156,630 | 6,000 | |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Option Exercise | A | 20.47 | 20,000 | 409,300 | 20,000 | |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Grant | A | 54.48 | 1,193 | 64,995 | 2,201 | 1 K to 2.2 K (+118.35 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Sell | S | 53.42 | 50,000 | 2,670,850 | 1,008 | 51 K to 1 K (-98.02 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Sell | S | 53.63 | 25,000 | 1,340,790 | 51,008 | 76 K to 51 K (-32.89 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Sell | S | 53.51 | 25,000 | 1,337,680 | 76,008 | 101 K to 76 K (-24.75 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Grant | A | 0.01 | 367 | 4 | 101,008 | 100.6 K to 101 K (+0.36 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Grant | A | 0.01 | 354 | 4 | 100,641 | 100.3 K to 100.6 K (+0.35 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Grant | A | 0.01 | 287 | 3 | 100,287 | 100 K to 100.3 K (+0.29 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.87 | 600 | 28,122 | 100,000 | 99.4 K to 100 K (+0.60 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.99 | 3,000 | 140,970 | 99,400 | 96.4 K to 99.4 K (+3.11 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.67 | 200 | 9,334 | 96,400 | 96.2 K to 96.4 K (+0.21 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.75 | 600 | 28,050 | 96,200 | 95.6 K to 96.2 K (+0.63 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.55 | 200 | 9,310 | 95,600 | 95.4 K to 95.6 K (+0.21 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.35 | 2,300 | 106,605 | 95,400 | 93.1 K to 95.4 K (+2.47 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.25 | 6,800 | 314,500 | 93,100 | 86.3 K to 93.1 K (+7.88 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.64 | 5,100 | 237,864 | 86,300 | 81.2 K to 86.3 K (+6.28 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.62 | 500 | 23,310 | 81,200 | 80.7 K to 81.2 K (+0.62 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.41 | 500 | 23,205 | 80,700 | 80.2 K to 80.7 K (+0.62 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.31 | 3,900 | 180,609 | 80,200 | 76.3 K to 80.2 K (+5.11 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 47.00 | 20,500 | 963,500 | 76,300 | 55.8 K to 76.3 K (+36.74 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.70 | 13,500 | 630,450 | 55,800 | 42.3 K to 55.8 K (+31.91 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.60 | 1,400 | 65,240 | 42,300 | 40.9 K to 42.3 K (+3.42 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.50 | 18,100 | 841,650 | 40,900 | 22.8 K to 40.9 K (+79.39 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.30 | 4,600 | 212,980 | 22,800 | 18.2 K to 22.8 K (+25.27 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.00 | 11,500 | 529,000 | 18,200 | 6.7 K to 18.2 K (+171.64 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.89 | 200 | 9,378 | 6,700 | 6.5 K to 6.7 K (+3.08 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.49 | 400 | 18,596 | 6,500 | 6.1 K to 6.5 K (+6.56 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.39 | 200 | 9,278 | 6,100 | 5.9 K to 6.1 K (+3.39 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 45.99 | 900 | 41,391 | 5,900 | 5 K to 5.9 K (+18.00 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.88 | 300 | 14,064 | 5,000 | 4.7 K to 5 K (+6.38 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.48 | 4,700 | 218,456 | 4,700 | 0 to 4.7 K |
Jul 30 2010 | HAE | HAEMONETICS CORP | Kelly Michael P | President, NA, Glob ... | Option Exercise | A | 54.97 | 31,270 | 1,718,912 | 31,270 | |
Jul 30 2010 | HAE | HAEMONETICS CORP | Kelly Michael P | President, NA, Glob ... | Grant | A | 54.97 | 2,183 | 120,000 | 2,183 | 0 to 2.2 K |
May 13 2010 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Sell | S | 57.02 | 9,000 | 513,171 | 5,722 | 14.7 K to 5.7 K (-61.13 %) |
May 04 2010 | HAE | HAEMONETICS CORP | White Jonathan | VP Research and Dev ... | Buy | P | 45.70 | 460 | 21,024 | 2,808 | 2.3 K to 2.8 K (+19.59 %) |
May 04 2010 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & Vice Presiden ... | Buy | P | 45.70 | 279 | 12,752 | 8,373 | 8.1 K to 8.4 K (+3.45 %) |
May 04 2010 | HAE | HAEMONETICS CORP | LOPEZ ALICIA R | VP, Corporate Affai ... | Buy | P | 45.70 | 318 | 14,534 | 11,009 | 10.7 K to 11 K (+2.97 %) |
May 04 2010 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Buy | P | 45.70 | 151 | 6,901 | 5,280 | 5.1 K to 5.3 K (+2.94 %) |
May 04 2010 | HAE | HAEMONETICS CORP | FORISH JOSEPH J | VP, Human Resources | Buy | P | 45.70 | 422 | 19,287 | 4,559 | 4.1 K to 4.6 K (+10.20 %) |
May 04 2010 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | D | 57.95 | 799 | 46,302 | 25,948 | 26.7 K to 25.9 K (-2.99 %) |
May 04 2010 | HAE | HAEMONETICS CORP | Brancazio Phillip John | VP, Global Manufact ... | Buy | P | 45.70 | 68 | 3,108 | 1,548 | 1.5 K to 1.5 K (+4.59 %) |
May 04 2010 | HAE | HAEMONETICS CORP | ALLEN PETER M | Chief Marketing Off ... | Buy | P | 45.70 | 308 | 14,077 | 7,865 | 7.6 K to 7.9 K (+4.08 %) |
Apr 29 2010 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Option Exercise | M | 22.91 | 9,000 | 206,157 | 0 | |
Apr 29 2010 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Buy | M | 22.91 | 9,000 | 206,157 | 14,722 | 5.7 K to 14.7 K (+157.29 %) |
Apr 20 2010 | HAE | HAEMONETICS CORP | LOPEZ ALICIA R | VP, Corporate Affai ... | Option Exercise | M | 22.91 | 10,867 | 248,923 | 0 | |
Apr 20 2010 | HAE | HAEMONETICS CORP | LOPEZ ALICIA R | VP, Corporate Affai ... | Sell | S | 60.00 | 20,000 | 1,200,000 | 10,691 | 30.7 K to 10.7 K (-65.17 %) |
Apr 20 2010 | HAE | HAEMONETICS CORP | LOPEZ ALICIA R | VP, Corporate Affai ... | Sell | S | 60.00 | 10,867 | 652,020 | 30,691 | 41.6 K to 30.7 K (-26.15 %) |
Apr 20 2010 | HAE | HAEMONETICS CORP | LOPEZ ALICIA R | VP, Corporate Affai ... | Buy | M | 22.91 | 10,867 | 248,923 | 41,558 | 30.7 K to 41.6 K (+35.41 %) |
Apr 15 2010 | HAE | HAEMONETICS CORP | RUXIN MICHAEL I | VP Global Software ... | Option Exercise | A | 57.63 | 105,000 | 6,051,150 | 105,000 | |
Apr 08 2010 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 56.31 | 165 | 9,291 | 26,747 | 26.9 K to 26.7 K (-0.61 %) |
Apr 01 2010 | HAE | HAEMONETICS CORP | HAEMONETICS CORP | 10% Owner | Buy | J | 1.22 | 1,036,776 | 1,264,867 | 35,434,828 | 34.4 M to 35.4 M (+3.01 %) |
Apr 01 2010 | HAE | HAEMONETICS CORP | HAEMONETICS CORP | 10% Owner | Buy | J | 1.22 | 406,519 | 495,953 | 34,398,052 | 34 M to 34.4 M (+1.20 %) |
Apr 01 2010 | HAE | HAEMONETICS CORP | HAEMONETICS CORP | 10% Owner | Buy | J | 1.22 | 41,000 | 50,020 | 33,991,533 | 34 M to 34 M (+0.12 %) |
Apr 01 2010 | HAE | HAEMONETICS CORP | HAEMONETICS CORP | 10% Owner | Buy | J | 1.22 | 1,590,800 | 1,940,776 | 33,950,533 | 32.4 M to 34 M (+4.92 %) |
Apr 01 2010 | HAE | HAEMONETICS CORP | HAEMONETICS CORP | 10% Owner | Buy | J | 1.22 | 827,303 | 1,009,310 | 32,359,733 | 31.5 M to 32.4 M (+2.62 %) |
Apr 01 2010 | HAE | HAEMONETICS CORP | HAEMONETICS CORP | 10% Owner | Buy | J | 1.22 | 103,700 | 126,514 | 31,532,430 | 31.4 M to 31.5 M (+0.33 %) |
Mar 26 2010 | HAE | HAEMONETICS CORP | NUTTER BRAD | Chairman of the Boa ... | Option Exercise | M | 41.15 | 26,872 | 1,105,783 | 0 | |
Mar 26 2010 | HAE | HAEMONETICS CORP | NUTTER BRAD | Chairman of the Boa ... | Sell | S | 57.00 | 26,872 | 1,531,731 | 9,387 | 36.3 K to 9.4 K (-74.11 %) |
Mar 26 2010 | HAE | HAEMONETICS CORP | NUTTER BRAD | Chairman of the Boa ... | Buy | M | 41.15 | 26,872 | 1,105,783 | 36,259 | 9.4 K to 36.3 K (+286.27 %) |
Mar 24 2010 | HAE | HAEMONETICS CORP | NUTTER BRAD | Chairman of the Boa ... | Option Exercise | M | 41.15 | 100 | 4,115 | 26,872 | |
Mar 24 2010 | HAE | HAEMONETICS CORP | NUTTER BRAD | Chairman of the Boa ... | Option Exercise | M | 41.15 | 30,700 | 1,263,305 | 26,972 | |
Mar 24 2010 | HAE | HAEMONETICS CORP | NUTTER BRAD | Chairman of the Boa ... | Option Exercise | M | 41.15 | 142,328 | 5,856,797 | 57,672 | |
Mar 24 2010 | HAE | HAEMONETICS CORP | NUTTER BRAD | Chairman of the Boa ... | Sell | S | 57.00 | 100 | 5,700 | 9,387 | 9.5 K to 9.4 K (-1.05 %) |
Mar 24 2010 | HAE | HAEMONETICS CORP | NUTTER BRAD | Chairman of the Boa ... | Buy | M | 41.15 | 100 | 4,115 | 9,487 | 9.4 K to 9.5 K (+1.07 %) |
Mar 24 2010 | HAE | HAEMONETICS CORP | NUTTER BRAD | Chairman of the Boa ... | Sell | S | 57.00 | 30,700 | 1,749,906 | 9,387 | 40.1 K to 9.4 K (-76.58 %) |
Mar 24 2010 | HAE | HAEMONETICS CORP | NUTTER BRAD | Chairman of the Boa ... | Buy | M | 41.15 | 30,700 | 1,263,305 | 40,087 | 9.4 K to 40.1 K (+327.05 %) |
Mar 24 2010 | HAE | HAEMONETICS CORP | NUTTER BRAD | Chairman of the Boa ... | Sell | S | 57.00 | 142,328 | 8,112,696 | 9,387 | 151.7 K to 9.4 K (-93.81 %) |
Mar 24 2010 | HAE | HAEMONETICS CORP | NUTTER BRAD | Chairman of the Boa ... | Buy | M | 41.15 | 142,328 | 5,856,797 | 151,715 | 9.4 K to 151.7 K (+1,516.22 %) |
Feb 19 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Sell | S | 53.42 | 50,000 | 2,670,850 | 1,008 | 51 K to 1 K (-98.02 %) |
Feb 18 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Sell | S | 53.63 | 25,000 | 1,340,790 | 51,008 | 76 K to 51 K (-32.89 %) |
Feb 18 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Sell | S | 53.51 | 25,000 | 1,337,680 | 76,008 | 101 K to 76 K (-24.75 %) |
Feb 12 2010 | HAE | HAEMONETICS CORP | ALLEN PETER M | Chief Marketing Off ... | Option Exercise | M | 21.46 | 2,200 | 47,212 | 89,580 | |
Feb 12 2010 | HAE | HAEMONETICS CORP | ALLEN PETER M | Chief Marketing Off ... | Sell | S | 52.56 | 2,200 | 115,632 | 7,557 | 9.8 K to 7.6 K (-22.55 %) |
Feb 12 2010 | HAE | HAEMONETICS CORP | ALLEN PETER M | Chief Marketing Off ... | Buy | M | 21.46 | 2,200 | 47,212 | 9,757 | 7.6 K to 9.8 K (+29.11 %) |
Nov 03 2009 | HAE | HAEMONETICS CORP | White Jonathan | VP Research and Dev ... | Buy | P | 44.13 | 480 | 21,183 | 2,348 | 1.9 K to 2.3 K (+25.70 %) |
Nov 03 2009 | HAE | HAEMONETICS CORP | LOPEZ ALICIA R | VP, Corporate Affai ... | Buy | P | 44.13 | 87 | 3,839 | 30,691 | 30.6 K to 30.7 K (+0.28 %) |
Nov 03 2009 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & Vice Presiden ... | Buy | P | 44.13 | 166 | 7,326 | 8,094 | 7.9 K to 8.1 K (+2.09 %) |
Nov 03 2009 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Buy | P | 44.13 | 155 | 6,840 | 5,129 | 5 K to 5.1 K (+3.12 %) |
Nov 03 2009 | HAE | HAEMONETICS CORP | ALLEN PETER M | Chief Marketing Off ... | Buy | P | 44.13 | 131 | 5,781 | 7,557 | 7.4 K to 7.6 K (+1.76 %) |
Oct 29 2009 | HAE | HAEMONETICS CORP | Gordon Mikael | President, Haemonet ... | Option Exercise | A | 52.94 | 19,587 | 1,036,936 | 19,587 | |
Oct 29 2009 | HAE | HAEMONETICS CORP | Gordon Mikael | President, Haemonet ... | Grant | A | 0.00 | 1,224 | 0 | 3,362 | 2.1 K to 3.4 K (+57.25 %) |
Oct 29 2009 | HAE | HAEMONETICS CORP | Gordon Mikael | President, Haemonet ... | Option Exercise | A | 54.55 | 15,247 | 831,724 | 15,247 | |
Oct 29 2009 | HAE | HAEMONETICS CORP | Gordon Mikael | President, Haemonet ... | Grant | A | 0.01 | 952 | 10 | 2,138 | 1.2 K to 2.1 K (+80.27 %) |
Oct 29 2009 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | A | 52.94 | 79,675 | 4,217,995 | 79,675 | |
Oct 29 2009 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Grant | A | 0.00 | 4,979 | 0 | 26,912 | 21.9 K to 26.9 K (+22.70 %) |
Oct 29 2009 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & Vice Presiden ... | Option Exercise | A | 52.94 | 22,036 | 1,166,586 | 22,036 | |
Oct 29 2009 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & Vice Presiden ... | Grant | A | 0.00 | 1,377 | 0 | 7,928 | 6.6 K to 7.9 K (+21.02 %) |
Oct 29 2009 | HAE | HAEMONETICS CORP | ALLEN PETER M | Chief Marketing Off ... | Option Exercise | A | 52.94 | 15,670 | 829,570 | 15,670 | |
Oct 29 2009 | HAE | HAEMONETICS CORP | ALLEN PETER M | Chief Marketing Off ... | Grant | A | 0.00 | 979 | 0 | 7,426 | 6.4 K to 7.4 K (+15.19 %) |
Oct 29 2009 | HAE | HAEMONETICS CORP | FORISH JOSEPH J | VP, Human Resources | Option Exercise | A | 52.94 | 14,690 | 777,689 | 14,690 | |
Oct 29 2009 | HAE | HAEMONETICS CORP | FORISH JOSEPH J | VP, Human Resources | Grant | A | 0.00 | 918 | 0 | 4,137 | 3.2 K to 4.1 K (+28.52 %) |
Oct 29 2009 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Option Exercise | A | 52.94 | 7,345 | 388,844 | 7,345 | |
Oct 29 2009 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Grant | A | 0.00 | 459 | 0 | 4,974 | 4.5 K to 5 K (+10.17 %) |
Oct 29 2009 | HAE | HAEMONETICS CORP | LOPEZ ALICIA R | VP, Corporate Affai ... | Option Exercise | A | 52.94 | 7,732 | 409,332 | 7,732 | |
Oct 29 2009 | HAE | HAEMONETICS CORP | LOPEZ ALICIA R | VP, Corporate Affai ... | Grant | A | 0.00 | 483 | 0 | 30,604 | 30.1 K to 30.6 K (+1.60 %) |
Oct 29 2009 | HAE | HAEMONETICS CORP | Brancazio Phillip John | VP, Global Manufact ... | Option Exercise | A | 52.94 | 12,242 | 648,091 | 12,242 | |
Oct 29 2009 | HAE | HAEMONETICS CORP | Brancazio Phillip John | VP, Global Manufact ... | Grant | A | 0.00 | 765 | 0 | 1,480 | 715 to 1.5 K (+106.99 %) |
Oct 29 2009 | HAE | HAEMONETICS CORP | White Jonathan | VP Research and Dev ... | Option Exercise | A | 52.94 | 12,242 | 648,091 | 12,242 | |
Oct 29 2009 | HAE | HAEMONETICS CORP | White Jonathan | VP Research and Dev ... | Grant | A | 0.00 | 765 | 0 | 1,868 | 1.1 K to 1.9 K (+69.36 %) |
Oct 27 2009 | HAE | HAEMONETICS CORP | LOPEZ ALICIA R | VP, Corporate Affai ... | Sell | S | 54.52 | 71 | 3,871 | 30,121 | 30.2 K to 30.1 K (-0.24 %) |
Oct 27 2009 | HAE | HAEMONETICS CORP | LOPEZ ALICIA R | VP, Corporate Affai ... | Sell | S | 54.24 | 72 | 3,905 | 30,192 | 30.3 K to 30.2 K (-0.24 %) |
Oct 27 2009 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & Vice Presiden ... | Sell | S | 54.52 | 107 | 5,834 | 6,551 | 6.7 K to 6.6 K (-1.61 %) |
Oct 27 2009 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Sell | S | 54.52 | 72 | 3,925 | 4,515 | 4.6 K to 4.5 K (-1.57 %) |
Oct 27 2009 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Sell | S | 54.24 | 73 | 3,960 | 4,587 | 4.7 K to 4.6 K (-1.57 %) |
Oct 27 2009 | HAE | HAEMONETICS CORP | FORISH JOSEPH J | VP, Human Resources | Sell | S | 54.52 | 60 | 3,271 | 3,219 | 3.3 K to 3.2 K (-1.83 %) |
Oct 27 2009 | HAE | HAEMONETICS CORP | FORISH JOSEPH J | VP, Human Resources | Sell | S | 54.24 | 60 | 3,254 | 3,279 | 3.3 K to 3.3 K (-1.80 %) |
Oct 27 2009 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 53.40 | 117 | 6,248 | 21,933 | 22.1 K to 21.9 K (-0.53 %) |
Oct 27 2009 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 54.24 | 143 | 7,756 | 22,050 | 22.2 K to 22.1 K (-0.64 %) |
Oct 27 2009 | HAE | HAEMONETICS CORP | ALLEN PETER M | Chief Marketing Off ... | Sell | S | 54.52 | 92 | 5,016 | 6,447 | 6.5 K to 6.4 K (-1.41 %) |
Oct 27 2009 | HAE | HAEMONETICS CORP | ALLEN PETER M | Chief Marketing Off ... | Sell | S | 54.24 | 77 | 4,176 | 6,539 | 6.6 K to 6.5 K (-1.16 %) |
Oct 13 2009 | HAE | HAEMONETICS CORP | ALLEN PETER M | Chief Marketing Off ... | Option Exercise | M | 21.46 | 1,870 | 40,130 | 91,780 | |
Oct 13 2009 | HAE | HAEMONETICS CORP | ALLEN PETER M | Chief Marketing Off ... | Sell | S | 55.66 | 1,870 | 104,088 | 6,616 | 8.5 K to 6.6 K (-22.04 %) |
Oct 13 2009 | HAE | HAEMONETICS CORP | ALLEN PETER M | Chief Marketing Off ... | Buy | M | 21.46 | 1,870 | 40,130 | 8,486 | 6.6 K to 8.5 K (+28.26 %) |
Sep 21 2009 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Option Exercise | M | 27.34 | 6,000 | 164,063 | 0 | |
Sep 21 2009 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Sell | S | 55.78 | 6,000 | 334,697 | 5,722 | 11.7 K to 5.7 K (-51.19 %) |
Sep 21 2009 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Buy | M | 27.34 | 6,000 | 164,063 | 11,722 | 5.7 K to 11.7 K (+104.86 %) |
Aug 03 2009 | HAE | HAEMONETICS CORP | NUTTER BRAD | Chairman of the Boa ... | Option Exercise | A | 59.44 | 5,879 | 349,448 | 5,879 | |
Aug 03 2009 | HAE | HAEMONETICS CORP | NUTTER BRAD | Chairman of the Boa ... | Grant | A | 0.01 | 367 | 4 | 9,387 | 9 K to 9.4 K (+4.07 %) |
Aug 03 2009 | HAE | HAEMONETICS CORP | MERRIMAN RONALD | Director | Option Exercise | A | 59.44 | 5,879 | 349,448 | 5,879 | |
Aug 03 2009 | HAE | HAEMONETICS CORP | MERRIMAN RONALD | Director | Grant | A | 0.01 | 367 | 4 | 4,008 | 3.6 K to 4 K (+10.08 %) |
Aug 03 2009 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Option Exercise | A | 59.44 | 5,879 | 349,448 | 5,879 | |
Aug 03 2009 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Grant | A | 0.01 | 367 | 4 | 1,008 | 641 to 1 K (+57.25 %) |
Aug 03 2009 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Option Exercise | A | 59.44 | 5,879 | 349,448 | 5,879 | |
Aug 03 2009 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Grant | A | 0.01 | 367 | 4 | 10,308 | 9.9 K to 10.3 K (+3.69 %) |